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In prior studies, we demonstrated that glucuronoxylomannan (GXM), the major capsular polysaccharide of the fungal pathogen
Cryptococcus neoformans, interacts with chitin oligomers at the cell wall-capsule interface. The structural determinants regulat-
ing these carbohydrate-carbohydrate interactions, as well as the functions of these structures, have remained unknown. In this
study, we demonstrate that glycan complexes composed of chitooligomers and GXM are formed during fungal growth andmac-
rophage infection by C. neoformans. To investigate the required determinants for the assembly of chitin-GXM complexes, we
developed a quantitative scanning electronmicroscopy-based method using different polysaccharide samples as inhibitors of the
interaction of chitin with GXM. This assay revealed that chitin-GXM association involves noncovalent bonds and large GXM
fibers and depends on theN-acetyl amino group of chitin. Carboxyl andO-acetyl groups of GXM are not required for polysac-
charide-polysaccharide interactions. Glycan complex structures composed of cryptococcal GXM and chitin-derived oligomers
were tested for their ability to induce pulmonary cytokines in mice. They were significantly more efficient than either GXM or
chitin oligomers alone in inducing the production of lung interleukin 10 (IL-10), IL-17, and tumor necrosis factor alpha (TNF-
). These results indicate that association of chitin-derived structures with GXM through theirN-acetyl amino groups generates
glycan complexes with previously unknown properties.
Cryptococcosis is a life-threatening disease caused by the yeast-like pathogensCryptococcus neoformans andC. gattii. This sys-
temic mycosis is rampant in Africa, where mortality indices of
cryptococcosis exceed those of tuberculosis (37). Currently avail-
able anticryptococcal therapies are unsatisfactory such that high
mortality and morbidity, drug resistance, and recurrence of
treated infection are relatively common (4).
Cryptococcal cells are coated by a polysaccharide capsule that
contributes to virulence through multiple mechanisms (46). Al-
though it is accepted that capsule formation and its assembly are
necessary for pathogenesis (38), many structural and functional
aspects of capsular components remain unknown (42). The cryp-
tococcal capsule contains the polysaccharides glucuronoxylo-
mannan (GXM) and glucuronoxylomannogalactan (GXMGal)
(previously called galactoxylomannan) (46). GXM is the major
capsular component, accounting for approximately 85% of the
capsular mass. This polysaccharide is the main virulence factor of
C. neoformans (31), and its neutralization by passively adminis-
teredmonoclonal antibodies is associatedwith disease control (6).
GXM is also a prototype of vaccine development (8).
Capsule assembly in C. neoformans is a complex event, and the
mechanisms by which polysaccharide components are organized
to form this structure are only now beginning to be elucidated
(24). Carbohydrate-carbohydrate interactions are presumably re-
quired for capsule organization and, in fact, GXM interacts with
other polysaccharidemolecules at the cell surface (46). Self-aggre-
gation (GXM-GXM interactions) is required for capsule enlarge-
ment (24, 35), but the polysaccharide is also likely to interact with
cell wall glucans, which are essential for capsule anchoring and cell
wall architecture (14, 25, 39, 40). Microscopic examination re-
vealed that GXM is also associated with GXMGal at the capsular
network (17). Therefore, assuming that GXM is linked to other
components of the capsule, glycan complexes are presumably
formed, but the function of these complexes is still unknown.
Our recent studies demonstrated that GXM interacts with chi-
tin-like structures within the capsular matrix by combining light
scattering analysis, fluorescence microscopy, and chromato-
graphic methodology (21, 41). Chitin and oligomeric subunits
(chitooligomers) consist of -1,4-linked units of N-acetylgluco-
samine (GlcNAc). In C. neoformans, chitin is synthesized through
the activities of eight different chitin synthases, and the de-N-
acetylated form, called chitosan, is also found (1, 2). Inhibition of
chitin-related molecule synthesis through the use of a synthetic
inhibitor resulted in the formation of faulty capsules (21), suggest-
ing that chitin-GXM association contributes to correct capsule
assembly. In fact, complexes formed by chitin-derived oligomers
and GXM are formed in association with the capsule or in soluble
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form during regular growth of C. neoformans (21). Thus, assum-
ing that the association of chitin-like molecules with GXM is in
fact physiological, a glycan complex is putatively formed during
the regular metabolism of C. neoformans. However, despite the
potential relevance of these structures for capsule assembly and
pathogenesis (21), it is still unknown whether they affect the in-
teraction of C. neoformans with the host. The structural determi-
nants regulating the interaction of chitin with GXM were also
unknown and have been investigated in the present work.
In this study, we investigated whether glycan complexes
formed by GXM and chitin-like molecules would be formed dur-
ing macrophage infection by C. neoformans and if they would
differ in function from each polysaccharide/oligosaccharide com-
ponent tested separately. We detected glycan complexes during
infection of the phagocytes by encapsulated fungi and observed
that these complexes were significantly more efficient than either
GXM or oligomeric chitin structures alone to induce the produc-
tion of lung cytokines in mice. Formation of glycan complexes
depended on themass of GXMfibers, noncovalent bonds, and the
N-acetyl groups of chitin. These observations suggest the occur-
rence of cryptococcal hybrid molecules with previously unknown
functions and with the potential to influence the pathogenesis of
C. neoformans.
MATERIALS AND METHODS
Microorganismandgrowth conditions.TheC. neoformans strain used in
most experiments described in this study was the standard serotype A
isolate H99. The only exception was the assay that sought to detect glycan
complexes after fungal growth ormacrophage infection, where the heavily
encapsulated ATCC 24067 isolate (serotype D) and the acapsular mutant
strain Cap67 were also included. Yeast cells were inoculated into 100-ml
Erlenmeyer flasks containing 50 ml of minimal medium composed of 15
mM glucose, 10 mM MgSO4, 29.4 mM KH2PO4, 13 mM glycine, and 3
M thiamine-HCl (pH 5.5). Fungal cells were cultivated for 2 days at
30°C, with shaking. Yeast cells were obtained by centrifugation, washed in
phosphate-buffered saline (PBS), and counted in a Neubauer chamber.
All media were prepared with apyrogenic water, and glassware was ren-
dered sterile and free of pyrogen by heating at 190°C for 4 h.
GXM fractionation and chemical modifications. GXM was isolated
as described previously (35) by sequential filtration of fungal supernatants
in Amicon ultrafiltration cells (cutoffs, 1, 10, 100, and 300 kDa;Millipore,
Danvers, MA). After concentration of the supernatant, the viscous GXM-
containing film layer was collected with a cell scraper and was transferred
to plastic tubes. GXM was chemically modified using standard tech-
niques. Carboxyl-reduced GXMwas prepared as described by Taylor and
Conrad (43), with conversion of approximately 60% of the glucuronyl
residues into glucose (not shown). Removal of O-acetyl groups was per-
formed by dissolving 5 mg of GXM in 1 ml of H2O adjusted to pH 11.25
with NH4OH. The resulting solution was stirred for 24 h at 23°C and
dialyzed against water. For polysaccharide quantification, capture en-
zyme-linked immunosorbent assay (ELISA) (7), carbazole reaction for
hexuronic acid (18), and the method of Dubois et al. for hexose detection
(19) were used. In all experiments, lipopolysaccharide (LPS)-free water
and plastic material were used.
Quantitative assay of polysaccharide-polysaccharide interactions.
The interaction of chitin with GXMwas determined based on the follow-
ing: (i) the cells of C. neoformans contain abundant amounts of surface
GXM (46) and (ii) particles of commercial chitin (isolated from shrimp;
Sigma-Aldrich) are insoluble in water and therefore can be handled and
separated by regular techniques for cell fractionation and visualization.
Thus, considering the previously described affinity of chitin for GXM
(21), we used chitin particles for interaction with GXM fibers on the
surface ofC. neoformans. In this case, the complex formed by chitin andC.
neoformans could be visualized and quantified by scanning electron mi-
croscopy (SEM). This method was validated in initial tests developed in
our laboratory, and optimized protocols are described. The specificity of
GXM binding to chitin and the structural determinants involved in this
interaction were assessed by inhibition of complex formation as summa-
rized in Table 1.
C. neoformans cells (107 cells) were washed three times with PBS by
centrifugation and incubated in the presence of 2 mg of chitin for 12 h at
room temperature with stirring in minimal medium. Suspensions con-
taining yeast cells or chitin alone were prepared following the same pro-
tocol. In some experiments, the insoluble particles of chitin were replaced
by cellulose, a polymer composed of repeating units of -1,4-linked glu-
cose. Chitin-C. neoformans complexes were washed extensively in PBS by
centrifugation and fixed in 0.1 M sodium cacodylate buffer containing
2.5% glutaraldehyde for 1 h. The complexes were then washed in a buffer
containing 0.1 M sodium cacodylate, 0.2 M sucrose, and 2 mM MgCl2.
The samples were fixed on coverslips coatedwith poly-L-lysine for 20min.
Preparations were then serially subjected to dehydration in alcohol (30%,
50%, and 70% for 5 min and 95% and 100% for 10 min), critical point
drying, and metallization. The complexes were observed in a scanning
electron microscope (JEOL JSM-5310). Quantification of the formation
of chitin-C. neoformans complexes by SEM was achieved by counting the
number of yeast cells adhered per polysaccharide particle permicroscopic
field (minimum of 10 fields). In this analysis, only chitin particles within
the range of 40 to 60 m were considered.
The structural determinants involved in the interaction of cryptococ-
cal GXMwith chitinwere examined by the inclusion of several blocking or
competing agents in the experimental system described above. Specificity
was first evaluated by the incubation of chitin-free particles with wheat
germ agglutinin (WGA) at 100 g/ml for 1 h at room temperature before
adding C. neoformans cells. WGA recognizes oligomeric sequences of
TABLE 1 Analytical models for analysis of the interaction of GXM with chitin
Structural aspect assessed Approach used
Molecular specificity of C. neoformans-chitin
interaction
Pretreatment of the chitin particles with WGA or with soluble GXM; pretreatment of yeasts with
anti-GXM
Involvement of noncovalent bonds Treatment of chitin-C. neoformans complexes with urea, NaCl, and EDTA
Requirement of O-acetyl groups of GXM Pretreatment of the chitin particles with de-O-acetylated GXM and comparison with results obtained
with samples of native GXM; treatment of yeast cells with de-O-acetylating agent, followed by
incubation with chitin particles
Requirement of carboxyl groups of GXM Pretreatment of the chitin particles with carboxyl-reduced GXM, followed by comparison with
results obtained with samples of native GXM
Influence of GXMmolecular mass Treatment of chitin-C. neoformans complexes with EDTA; pretreatment of chitin particles with
fractions containing GXM with different molecular masses
Requirement of chitin amino groups Replacement of chitin by cellulose in SEM tests
Requirement of N-acetyl groups from chitin Pretreatment of yeast cells with chitosan
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-1,4-N-acetylglucosamine. Alternatively, chitin particles were incubated
with purifiedGXMsamples using either the native polysaccharide or sam-
ples that were de-O-acetylated, carboxyl reduced, or fractionated accord-
ing to molecular mass. All these preincubations were performed with
samples of GXM at 100 g/ml in PBS. After extensive washing by centrif-
ugation, the suspensions containing particles of chitin were incubated
with C. neoformans cells as described above, followed by preparation for
SEM. Additional systems included preincubation of fungi with themono-
clonal antibody (MAb) to GXM MAb 18B7, chitosan, N-acetylgluco-
samine, or chitotriose [(GlcNAc)3], all at 100 g/ml. Owing to chitin
insolubility, the chitooligomer (GlcNAc)3was used in assays that required
GlcNAc-containing structures in their water-soluble form. After washing,
yeast cells were incubated with chitin as described above. To assess
whether noncovalent interactions were involved in GXM-chitin interac-
tion, the complexes formed as described above were washed in PBS, sus-
pended in EDTA (100 mM), NaCl (1 M), or urea (8 M), and stirred for 1
h at room temperature for subsequent SEM analysis.
Preparation of glycan complexes. GXM and chitotriose (GlcNAc)3
were dissolved in minimal medium to form a solution in which each
molecule reached the final concentration of 3 mg/ml. This solution was
incubated overnight at 25°C and extensively washed with minimal me-
dium in a Centricon ultrafiltration system (10 kDa cutoff) to remove
unbound oligomers. GXM-(GlcNAc)3 associationwasmonitored by light
scattering analysis as described recently (21) (data not shown). GXM
alone was subjected to the same conditions.
Mice immunization and cytokine determination. Female BALB/c
mice (4 to 8 weeks old; n  5) were anesthetized intraperitoneally with
ketamine (0.125mg/g) and xylazine (0.01mg/g). Animals were then given
50l of a PBS solution of GXM, chitotriose (GlcNAc)3, or a combination
of both, all at 500 g/ml intranasally. Mice were sacrificed 24 h after
immunization by cervical hyperextension. Lungs were then excised,
weighed, and macerated in PBS with a cell strainer for cytokine determi-
nation using the DuoSet ELISA development system kit (R&D System).
Interleukins 17 and 10 (IL-17 and IL-10) and tumor necrosis factor alpha
(TNF-) were chosen as the prototypes for cytokine tests based on previ-
ous literature on the anticryptococcal immunity (11, 32) and chitin-in-
duced cellular responses (15, 16). Cytokine contents were normalized to
the mass of lungs removed from each animal. For all experiments, LPS-
free water and glassware were used.
Preparation of antibody-coated polystyrene beads. Polystyrene
spheres (108, 3-mdiameter) were incubated for 1 h under gentle stirring
in a 10 g/ml solution of MAb 18B7 at room temperature. The spheres
were washed in PBS by centrifugation and blocked for 1 h at room tem-
perature in PBS-bovine serum albumin (BSA). After washing with PBS,
the spheres were suspended in Dulbecco’s modified Eagle’s medium
(DMEM) and used for precipitation of polysaccharides as described
below.
Precipitation of glycan complexes from supernatants of fungal cul-
tures and infected phagocytes. Fungal cells (strain Cap67 or ATCC
24067) were incubated in culture medium as described above for times
varying from 15 min to 12 h. Supernatants (1-ml samples) were collected
and centrifuged at 10,000 g for the removal of cells and debris, and the
MAb 18B7-coated spheres (final density, 108 spheres/ml) were then
added. The suspension was stirred for 1 h at room temperature to precip-
itate GXM-relatedmolecules. To evaluate whether glycan complexes were
precipitated by this methodology, the beads were incubated with tetra-
methyl rhodamine isocyanate (TRITC)-labeled WGA (30 min, 5 g/ml).
After washing, the spheres were analyzed in a FACSCalibur flow cytome-
ter as described previously (3). The possible participation of fungal chiti-
nases on the formation of the hybrid glycan complexes was evaluated in
experimental systemswhere themediumwas supplementedwith 3-meth-
ylxanthine, an inhibitor of fungal chitinases (44). Methylxanthine was
used at final concentrations corresponding to 0.05 and 0.5 mM, at which
no antifungal activity was observed (44). Control preparations for all sys-
tems were developed as described above by incubating antibody-coated
spheres with sterile medium or with supernatants obtained at time zero of
incubation. Additional controls included experiments where encapsu-
lated C. neoformans was replaced by the acapsular strain Cap67. For de-
tection of the complexes during macrophage infection, the murine mac-
rophage-like cell line RAW 264.7 (ATCC) was cultivated under LPS-free
conditions in complete DMEM supplemented with 10% fetal calf serum
(FCS), 2mM L-glutamine, 1mM sodiumpyruvate, 10mg/ml gentamicin,
minimal essentialmedium (MEM)nonessential amino acid solution (cat-
alog no. 11360; Gibco-Invitrogen), 10 mM HEPES, and 50 mM 2--
mercaptoethanol at 37°C under a 7.5% CO2 atmosphere as described
previously (36). For interaction with the phagocytes, fungal suspensions
(strain Cap67 or ATCC 24067) were prepared in DMEM at a ratio of 10
yeasts per macrophage (host cell). Interactions between fungi and host
cells were studied at 37°Cwith 5%CO2 for periods varying from15min to
12 h. Supernatants were collected and incubated with antibody-coated
spheres as described above. Treatment with TRITC-WGA and flow cy-
tometry analysis of the spheres were performed under the conditions de-
scribed above.
Statistical analysis. Student’s t test was used for comparison of two
different groups, and analysis of variance was used for comparison of
several groups. Statistical tests were performed with GraphPad Prism
(version 5.0).
RESULTS
Evaluation of the interaction between chitin and GXMby SEM.
Cryptococcal GXM has affinity for chitin (21). Based on this ob-
servation, we developed a quantitative scanning electron micros-
copy (SEM) method to investigate the structural determinants
required to form chitin-GXM complexes. Since GXM is abundant
at the surface of C. neoformans, the addition of exogenous insolu-
ble chitin particles formed aggregates containing encapsulated
yeast cells and chitin, which could then be visualized microscopi-
cally (Fig. 1A). Capsular fibers were seen as projections onto the
surface of chitin particles, suggesting that components of the cap-
sule were required for the association of C. neoformans with the
-1,4-GlcNAc polymer. In fact, treatment of chitin particles with
GXM before incubation with C. neoformans resulted in a marked
decrease in the number of yeast cells that adhered per particle of
chitin (Fig. 1B). Quantification of the number of yeast cells
adhered to chitin particles showed that the interaction of C. neo-
formans with the insoluble polysaccharide was inhibited by pre-
treatment with GXM (87% inhibition, P  0.001) or the chitin-
binding lectin WGA (72% inhibition, P 0.001), confirming the
specificity of this interaction. Treatment of C. neoformans with
MAb 18B7 before exposure to chitin produced similar results
(82% inhibition, P  0.001), which allowed us to validate the
model.
Chemical nature of chitin binding to GXM. Formation of ag-
gregates containing C. neoformans cells and chitin were sensitive
to treatment with chaotropic agents (NaCl and urea) (Fig. 2A; P
0.001 in comparison to untreated systems), suggesting that the
polysaccharide-polysaccharide interactions between GXM and
chitin involved noncovalent bonds. EDTA, a cation chelating
agent, produced an even stronger effect in comparison with both
urea and NaCl (Fig. 2A; P  0.05). Formation of the C. neofor-
mans-chitin aggregates in the presence of EDTA was also greatly
reduced (P 0.001).
Although chitin does not bind to divalent metals (5), GXM
associates strongly with Ca2 and Mg2 (35), which promotes
enlargement of polysaccharide fibers. EDTA could impair forma-
tion of chitin-C. neoformans aggregates by sequestering divalent
metals, which make salt bridges connecting GXM polymers, and
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consequently decreasing the mass of GXM fibers. In fact, the abil-
ity of GXM to block the interaction of chitin with C. neoformans
cells depended on its molecular mass (Fig. 2C). This observation
suggests that chitin interacts more efficiently with larger GXM
fibers.
We then investigated some structural features in GXM re-
quired for interaction with chitin.MannoseO-acetylation and the
carboxyl groups of this polysaccharide are known to regulate some
biological properties of the polysaccharide (29, 35). We observed
that interaction of control cryptococci or de-O-acetylated yeast
cells with chitin produced similar levels of binding (Fig. 3A; P 
0.7455), suggesting that O-acetyl groups are not required for the
carbohydrate-carbohydrate interaction studied in our model. In
fact, native GXM and its de-O-acetylated form were equally effi-
cient in blocking the binding of yeast cells to chitin (Fig. 3B; P
0.2602). Also, the use of GXM with reduced carboxyl groups to
FIG 1 Interaction of cryptococcal GXM with chitin as assayed by SEM. (A)
SEM analysis of aggregates formed after incubation of yeast cells with chitin in
minimal medium. Yeast capsular fibers (spherical forms) are apparently in
close contact with the surface of a chitin particle (larger and amorphous par-
ticle). At least 10 microscopic fields were examined in each system. Scale bar,
10 m. (B) Treatment of chitin particles with soluble GXM before incubation
with C. neoformans resulted in decreased number of yeast cells per chitin par-
ticle. Scale bar, 2 m. (C) Quantification of the results of the systems illus-
trated in panels A (Cn  Chitin [where Cn is C. neoformans]) and B (Cn 
GXM-Chitin) and also the effects of pretreatments of yeast cells with a mono-
clonal antibody to GXM (18B7-Cn  Chitin) and of chitin particles with a
chitin-binding lectin (CnWGA-Chitin). Results are expressed as means
standard deviations.
FIG 2 Chitin-GXM interactions involve noncovalent bonds and large GXM fibers. (A) Incubation of C. neoformans cells with chitin followed by exposure to
chaotropic molecules (NaCl and urea) or a chelating agent (EDTA) inhibits aggregate formation in comparison with systems that were exposed to PBS. (B)
Formation of themixed aggregates is impaired in the presence EDTA. (C) The use of GXM fractions of differentmolecularmasses to treat chitin before exposure
toC. neoformans cells reveals that samples of highermolecularmasses aremore effective in inhibiting the formation of cell-polysaccharide aggregates. Results are
expressed as means standard deviations.
FIG 3 GXM O-acetylation and glucuronic acid-associated negative charges
are not involved in interaction with chitin. (A) Incubation of standard (Cn) or
de-O-acetylated C. neoformans cells (de-O-Cn) with chitin results in similar
levels of association. (B) The use of native, de-O-acetylated (de-O-GXM) or
carboxyl-reduced (de-COOH) GXM fractions to treat chitin before exposure
to C. neoformans cells reveals that all samples had the same efficacy as inhibi-
tors of formation of cell-polysaccharide aggregates. Results are expressed as
means standard deviations.
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bind chitin before the cryptococci produced inhibitory effects that
were similar to those observed with native GXM (P  0.4609).
This result suggests that the negative charges associated to the
glucuronyl residues ofGXMare not involved in the binding of this
polysaccharide to chitin.
We then evaluated the structural features of chitin that were
required for interaction with GXM. GlcNAc, the building unit of
chitin, is an amino sugar. The amine group in chitin confers po-
larity and is required for nucleophilic interactions. When chitin
was replaced by cellulose that has -1,4-linked glucose and lacks
the N-acetyl amino group of chitin, we found that although C.
neoformans adhered to cellulose and this interaction was partially
inhibited by pretreatment with GXM, this association was weaker
than that observed when chitin was used (P 0.0001), indicating
that the N-acetyl amino groups of the GlcNAc polymer are likely
involved in chitin-GXM interactions (Fig. 4A). To specifically
evaluatewhether theN-acetylmoiety of this groupwas involved in
binding to GXM, the inhibitory potential of chitosan, the de-N-
acetylated form of chitin, was compared to those observed with a
chitin oligomer and the GlcNAc monosaccharide. Chitosan was
significantly less efficient in inhibiting the interaction of C. neo-
formans with chitin than GlcNAc and chitotriose (GlcNAc)3 (Fig.
4B; P  0.0002 and P  0.017, respectively), suggesting that N-
acetylation is an important feature in chitin-GXM interactions.
The higher efficacy of GlcNAc as an inhibitor is likely related to its
molar concentration (0.45 mM for GlcNAc versus 0.15 mM for
chitotriose, both corresponding to 100 g/ml). In summary, our
SEM-based model revealed that binding of GXM to chitin is non-
covalent, requiring large GXM fibers and the N-acetyl amino
group of chitin.
Formation of glycan complexes composed of GXM and chi-
tooligomers during C. neoformans growth. Glycan complexes
composed of GXM and chitooligomers were detected in C. neo-
formans cultures in a previous study (21). However, the kinetics of
formation of the hybrid glycan and the elements regulating this
process remain unknown. To address these questions, C. neofor-
manswas cultivated inminimal medium for periods varying from
15 min to 12 h for supernatant collection using the experimental
model described in Fig. 5A. Based on initial data aiming at exper-
imental optimization, strain H99, which was used in all experi-
ments in this study, was replaced by strain ATCC 24067 of C.
neoformans, a heavily encapsulated isolate with a high efficiency in
producing extracellular GXM (12, 35). Our approach was to pre-
cipitate soluble fractions of GXM released during fungal growth
and then test whether they came out associated with chitin-de-
rivedmolecules and, consequently, reacted withWGA. Sequential
incubation of supernatants with antibody-coated spheres and
TRITC-WGA did not give positive reactions (control). Similar
results were obtained at time zero (data not shown) and 15min of
incubation (Fig. 5B). After a 30-min incubation of C. neoformans
in the medium, however, glycan complexes were detected in ap-
proximately 25% of the antibody-coated spheres. This value pro-
gressively decreased to basal (control) levels after 120 min of in-
cubation of the fungus in minimal medium. After 12 h (720 min)
of growth, another peak of hybrid glycan detection was observed.
Based on the results described in Fig. 5B, the 30-min period of
incubation of the fungus in minimal medium was selected for
analysis of the specificity of glycan detection, as well as of possible
biological factors influencing its formation. Specificity was con-
firmed by experiments where encapsulated cells were replaced by
the Cap67 mutant of C. neoformans. In contrast to what was ob-
served for supernatants of encapsulated cells, detection of the
complexes containingGXMand chitooligomers was similar when
sterile culture medium and supernatants from the acapsular mu-
tant were tested (Fig. 5C).
To evaluate the role of fungal chitinases on the formation of
complexes containing GXM and chitooligosaccharides, incuba-
tion of the fungus for 30 min in culture medium followed by
glycan detection was performed in the presence of methylxan-
thine, an inhibitor of fungal chitinases (44). Detection of the com-
plexes containing GXM and chitooligomers was at the back-
ground level when the chitinase inhibitor was added to the
FIG 4 Requirement of amino groups andN-acetylation for the interaction of chitin with GXM. (A) Replacement of chitin by cellulose results in decreased levels
of attachment of C. neoformans (Cn) cells to chitin and reduced sensitivity to inhibition by previous exposure to GXM. (B) A chitooligomer [(GlcNAc)3] and
GlcNAc are more efficient than chitosan as inhibitors of the interaction of C. neoformans with chitin, as determined by comparison of systems in which fungal
cells were treatedwith PBS or the amino sugars before incubationwith chitinwith systems inwhich cryptococci were treatedwithminimalmediumalone. Results
are expressed as means standard deviations.
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medium (Fig. 5D), supporting the supposition that formation of
the hybrid molecule requires chitinase-mediated release of chitin
oligomers.
Detection of glycan complexes composed of GXM and chi-
tooligomers after macrophage infection byC. neoformans.Gly-
can complexes containing GXM and chitin-derived structures
could possibly exert differential biological functions compared to
GXM alone. We initially asked whether glycan complexes would
be formed spontaneously in soluble formduring the interaction of
C. neoformanswith host cells. Yeast (strain ATCC 24067) and host
cells were coincubated for periods varying from 15min to 12 h for
supernatant collection, followed by precipitation of the glycan
complexes as illustrated in Fig. 5A. During interaction of macro-
phages with C. neoformans, a peak of detection of the hybrid gly-
canswas observed after a 30-min incubation (Fig. 6). At this point,
96% of the antibody-coated beads were positive for the presence
of hybrid glycans. This number progressively decreased to ap-
proximately 7% after 2 h of incubation and reached less than 5%
after 12 h in contrast to what was observed for assays in the ab-
sence of host cells. Sequential incubation of supernatants of unin-
fected macrophages with antibody-coated spheres and TRITC-
WGAdid not give positive reactions (control). Experiments using
acapsular cells instead of encapsulated fungi also produced nega-
tive results (data not shown). We concluded that glycan com-
plexes containing GXM and chitin-derived structures could be
formed during infection of host cells by C. neoformans.
Glycan complexes induce a differential cytokine response in
infected mice compared with GXM and chitooligomers.Glycan
complexeswere preparedwith chitotriose andGXMand tested for
their ability to induce selected lung cytokines in mice (Fig. 7).
IL-10 determinations after 24 h of intranasal immunization with
each polysaccharide preparation revealed that both chitotriose
FIG 5 Formation of glycan complexes composed of GXM and chitin-derived structures during incubation of C. neoformans in culture medium. (A) Flow
cytometry-based experimentalmodel designed for detection of glycan complexes. (B) Reactivity of 18B7-coated spheres with TRITC-WGAafter incubationwith
culture supernatants. (C) Analysis of the reactivity of antibody-coated spheres with TRITC-WGA after incubation with sterile medium or after a 30-min
incubation of encapsulated or acapsular cells in the medium. (D) Effect of a chitinase inhibitor (3-methylxanthine) on the formation of glycan complexes in
cultures of C. neoformans incubated for 30 min at room temperature. Images are representative of three different experiments.
FIG 6 Formation of glycan complexes composed of GXM and chitin-derived structures during infection of macrophages by C. neoformans. (A) Reactivity of
18B7-coated spheres with TRITC-WGA after incubation with macrophage supernatants, incubated with C. neoformans for the periods indicated at the top of
each panel. (B) Kinetics of formation of the hybrid complexes based on the values obtained in panel A. Images are representative of three different experiments.
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and GXM tended to cause a decrease in the basal levels (mock
immunization) of the cytokine (P 0.05 for chitotriose and P
0.0008 for GXM). Immunization of mice with the glycan com-
plexes, however, induced a significantly higher IL-10 production
in comparison with controls (P 0.0091) and with (GlcNAc)3 or
GXM (P  0.023 and 0.003, respectively). The levels of IL-17 in
the lungs of control mice and of animals immunized with chito-
triosewere similar (P 0.7359). ImmunizationwithGXMtended
to cause an increase in lung IL-17 production, although the dif-
ference was not statistically significant (P 0.2477). Exposure of
mice to the glycan complexes, however, significantly enhanced
IL-17 production in comparison to immunization with chitotri-
ose and GXM separately (P  0.009 and 0.049, respectively). A
similar profile was observed for TNF- production. Altogether,
these results demonstrate that glycan complex structures pro-
duced enhanced immunosuppressive and proinflammatory cyto-
kine responses compared to a chitin oligomer and GXM alone.
DISCUSSION
In the current study, we examined some functional and structural
aspects of the interaction of GXM with chitin-like structures,
based on previous reports showing that both components inter-
acted within the capsular network (41) and in culture superna-
tants (21). GXM, the major capsular polysaccharide produced by
C. neoformans, is abundantly secreted in vitro and during animal
and human infections (46). The polysaccharide is extremely hy-
drophilic and has numerous motifs that can interact with neigh-
boring structures sharing H bonds (10) such as other polysaccha-
rides. In addition, GXM may function as a chelating agent (35),
sequestering divalent metals in different environments and estab-
lishing electrostatic bonds. Therefore, it is reasonable to assume
that, during infection, GXMmay exist either in its free form or in
association with other molecules potentially exhibiting still un-
known biological activities.
Studies on the bioactivity of GXM have been classically per-
formed with its free, soluble form. These studies may not reflect
the complete set of activities of thismajor capsular polysaccharide,
since a comparison between the properties of capsular-associated
and extracellular polysaccharide samples revealed differential bio-
physical properties, biological functions, and carbohydrate com-
positions (23). For instance, capsular extracts of C. neoformans
contained the building units of GXM but also large amounts of
glucose (23). It remains unknown, however, whether themodified
sugar compositions of capsular and extracellular extracts were due
to contamination with noncapsular molecules or whether GXM
was in fact associated with other polysaccharides in the capsule. In
this regard, it is clear that carbohydrate-carbohydrate interactions
are multiple within the capsule. Mutant C. neoformans cells lack-
ing the ability to synthesize -1,3-glucan also lost their ability to
anchor GXM to the cell wall (39, 40). GXM-GXM interactions
also occur in the capsule, and formation of these aggregates de-
pends on divalent metal bridges (35). Microscopic evidence sug-
gests that GXM and GXMGal are in close association in some
regions of the capsule (17, 28), and in fact, the basic components
of the Gal-containing polysaccharide are frequently detected in
samples prepared according to protocols aiming at GXM purifi-
cation (23). Apparently, mannoproteins also interact with capsu-
lar polysaccharides (28). Finally, confocal microscopy in combi-
nation with biochemical and biophysical methods revealed that
GXMassociates with chitin-derived structures in the capsularma-
trix and in culture supernatants (21, 41). The possibility thatGXM
takes part in complex glycan structures during the regular metab-
olism of C. neoformans led us to explore its ability to interact with
chitin-like structures, aiming at investigating whether such com-
plexes would manifest novel biological properties.
Glycan complexes composed of chitooligomers andGXMwere
isolated from both fungal supernatants and cultures of infected
macrophages, supporting the hypothesis that these structures can
be formed during both regular growth and infection. The profile
of formation of complex glycans as a function of time was differ-
ent when the fungus was cultivated in culture medium alone or in
the presence of macrophages. In fungal cultures, the usually high
rate of replication of C. neoformans may support a dynamic pro-
cess where the hybrid glycans are formed and degraded in regular
cycles, depending on the availability of GXM, chitooligomers, and
possibly hydrolases with affinity for these molecules. In the pres-
FIG 7 Cytokine determination in the lungs of mice exposed to PBS (control), chitooligomer [(GlcNAc)3; GlcNAc Oligo], GXM, or glycan complex structures.
Analysis of the production of IL-10 (A), IL-17 (B), and TNF- (C) revealed that the glycan complex structures aremuchmore efficient than chitin-like structures
or GXM alone in their ability to induce pulmonary cytokine responses.
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ence of macrophages, however, fungal viability is expect to vary
considerably (34), which may have a direct impact on the avail-
ability of GXM and chitin-derived structures in their soluble
forms. In this context, different kinetics of formation of the hybrid
polysaccharides would indeed be expected in these two experi-
mental models.
Chitooligomers are the products of enzymatic hydrolysis of
chitin. In this sense, it was described recently that chitinase expres-
sion is induced during animal pulmonary cryptococcosis (45) and
in the bronchoalveolar lavage fluid of asthmatic children (26), a
finding that has led to the proposal that this fungal product is
involved in the pathogenesis of some forms of asthma (27). The
surface expression of chitooligomers in C. neoformans is in fact
increased in the lung of infected rats (21). It is also likely that
chitooligomers produced through the activity of chitinase are re-
leased to the extracellular space, considering their high hydrophi-
licity and consequent solubility inwater. GXM, on the other hand,
is constitutively released to the extracellular space (46). We there-
fore raised the possibility that the chitooligomers formed in our
experimentalmodel were originated through the activity of fungal
chitinases, yielding molecules that could associate with GXM to
form glycan complexes. In fact, the hybrid glycans were detected
at background levels when C. neoformans was incubated in the
presence ofmethylxanthine, an inhibitor of fungal chitinases (44).
The effects of methylxanthines on cryptococcal molecules other
than chitinases are still unknown, which implies that the possibil-
ity of interference with additional biological events in C. neofor-
mans cannot be ruled out. The reduced formation of hybrid gly-
can complexes as a consequence of chitinase inhibition, however,
is in accordance with in vivo observations, demonstrating that
chitooligomer detection and capsule enlargement are more evi-
dent in host tissues manifesting higher activity of this enzyme
(21). In this sense, a putatively synergistic activity of host and
fungal chitinases (26, 44, 45) could provide an explanation for the
higher detection of glycan complexes in supernatants of infected
macrophages in comparison with the values observed for fungal
cultures.
Our observations indicate that the key structural determinants
mediating the interaction between chitin-like structures and
GXM are the N-acetyl groups present in the former. In C. neofor-
mans, chitin exists as polysaccharide and chitooligomeric forms
(21, 41). The de-N-acetylated form, or chitosan, is also present (1,
2). This polymer is required for cell wall integrity inC. neoformans
(1). Exposure of C. neoformans cells to chitosan induces capsule
reduction (30), suggesting that this chitin derivative and GXM
may also interact. The present study and previous work (20, 21,
41), however, suggest that chitin and chitooligomers have higher
affinity for GXM. Chitin had higher affinity for GXM fractions of
higher molecular mass. All polysaccharide fractions tested in the
present work had the same concentration, thus it is unlikely that
this observation would simply reflect a higher number of chitin-
binding sites. GXM tridimensional structure is highly complex
(13), and recent observations indicate that polysaccharide sam-
ples of different molecular masses manifest functional differences
(22). Thus, we believe that the superior efficacy of high molecular
mass fractions to interact with chitin may reflect still unknown
structural properties that would foster stable interactions between
both polysaccharides.
The ability of GXM to stimulate/inhibit neutrophil andmono-
cyte/macrophage cytokines has been extensively explored in the
literature (33). Chitin, on the other hand, is considered an immu-
nologically inert polysaccharide, although chitin particles of re-
duced dimensions contain pathogen-associated molecular pat-
terns that stimulate TLR2, dectin-1, and the mannose receptor
(15). The effects of the association of both polysaccharides, how-
ever, are unknown. In our model, complex glycan structures con-
taining GXM and chitooligomers were more efficient in inducing
the production of IL-10, IL-17, and TNF- than each molecule
alone in the lungs of mice. This observation indicates that glycan
complexes are functionally different from each molecule tested
individually and that they may influence the pathogenesis of C.
neoformans if produced during infection as they are in vitro (21).
Our results further highlightmolecular complexity of the cryp-
tococcal capsule and its constituents (13, 46). The attributes of the
capsular components have classically been examinedwith isolated
polysaccharide fractions (9), although a number of studies
strongly suggest that these molecules are associated to other com-
ponents of the cell surface of C. neoformans (14, 17, 20, 21, 28, 35,
39–41). Our results suggest that chitin-derived structures associ-
ate with GXM through their N-acetyl amino groups generating
complex glycans with previously unknown functions. We believe
that the present results will open new venues of investigation on
the functions of capsular components inC. neoformans, including
tests on the influence of other glycan complexes (e.g., GXM-
GXMGal) on the interaction of this pathogenwith elements of the
host immune response.
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